Brain Cancer Drug Discovery: Clinical Trials, Drug Classes, Targets, and Combinatorial Therapies-Reference-Cited by-同舟云学术

Brain Cancer Drug Discovery: Clinical Trials, Drug Classes, Targets, and Combinatorial Therapies

Published:2021-10 Issue:4 Volume:73 Page:1172-1203
ISSN:0031-6997
Container-title:Pharmacological Reviews
language:en
Short-container-title:Pharmacol Rev

Author:

Sokolov Aleksandr V.,Dostdar Samira A.,Attwood Misty M.,Krasilnikova Aleksandra A.,Ilina Anastasia A.,Nabieva Amina Sh.,Lisitsyna Anna A.,Chubarev Vladimir N.,Tarasov Vadim V.,Schiöth Helgi B.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference157 articles.

1. A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma);Agrawal;Front Pharmacol,2019

2. Biomanufacturing for clinically advanced cell therapies;Aijaz;Nat Biomed Eng,2018

3. Synergistic combination of oncolytic virotherapy with CAR T-cell therapy;Ajina;Prog Mol Biol Transl Sci,2019

4. Anti-angiogenic therapy for high-grade glioma;Ameratunga;Cochrane Database Syst Rev,2018

5. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov;Translational Psychiatry;2024-07-31

2. Adult brain tumour research in 2024: Status, challenges and recommendations;Neuropathology and Applied Neurobiology;2024-04

3. Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment;Frontiers in Chemistry;2024-01-08

4. Tumor Niches: Perspectives for Targeted Therapies in Glioblastoma;Antioxidants & Redox Signaling;2023-11-01

5. From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress;Signal Transduction and Targeted Therapy;2023-10-20